# Evaluation of the Safety and Efficacy of a Single Dose of a Dengue Vaccine (TV005) in Healthy Adults

> **NCT02317900** · PHASE1 · COMPLETED · sponsor: **National Institute of Allergy and Infectious Diseases (NIAID)** · enrollment: 48 (estimated)

## Conditions studied

- Dengue

## Interventions

- **BIOLOGICAL:** TV005
- **BIOLOGICAL:** Placebo
- **BIOLOGICAL:** rDEN2∆30-7169

## Key facts

- **NCT ID:** NCT02317900
- **Lead sponsor:** National Institute of Allergy and Infectious Diseases (NIAID)
- **Sponsor class:** NIH
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-12
- **Primary completion:** 2016-11
- **Final completion:** —
- **Target enrollment:** 48 (ESTIMATED)
- **Last updated:** 2017-02-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02317900

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02317900, "Evaluation of the Safety and Efficacy of a Single Dose of a Dengue Vaccine (TV005) in Healthy Adults". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT02317900. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*